A Novel, Picomolar Inhibitor of Human Immunodeficiency Virus Type 1 Protease
- 1 January 1996
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 39 (2) , 392-397
- https://doi.org/10.1021/jm9507183
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Risking Everything? Risk Behavior, Behavior Change, and AIDSScience, 1994
- Influence of stereochemistry on activity and binding modes for C2 symmetry-based diol inhibitors of HIV-1 proteaseJournal of the American Chemical Society, 1994
- Resistance of Human Immunodeficiency Virus Type 1 to Antiretroviral Agents: A ReviewClinical Infectious Diseases, 1994
- Regulation of MHC Class I Transport by the Molecular Chaperone, Calnexin (p88, IP90)Science, 1994
- [19] Advances in automated docking applied to human immunodeficiency virus type 1 proteasePublished by Elsevier ,1994
- [18] Design of symmetry-based, peptidomimetic inhibitors of human immunodeficiency virus proteasePublished by Elsevier ,1994
- Antiviral and pharmacokinetic properties of C2 symmetric inhibitors of the human immunodeficiency virus type 1 proteaseAntimicrobial Agents and Chemotherapy, 1991
- Novel Fluorogenic Substrates for Assaying Retroviral Proteases by Resonance Energy TransferScience, 1990
- Human immunodeficiency virus protease: A target for aids therapyDrug Development Research, 1990
- Dynamics of the multidomain fibrinolytic protein urokinase from two-dimensional NMRNature, 1989